Personalised oncology · Molecular diagnostics

Understand your tumour.Explore your treatment options.

Molecular profiling investigates genetic changes in a tumour. This information helps your oncologist assess possible targeted treatments, changes associated with treatment resistance, and opportunities to participate in clinical trials.

How molecular testing informs care

Individual biology

An individual approach to treatment planning.

Tumours with the same histological diagnosis can have different molecular and genetic characteristics. Molecular profiling helps oncologists identify biomarkers that may matter for treatment selection and the assessment of resistance to therapy.

DNA & RNA

Which genetic changes does the test examine?

Identifying clinically relevant genetic changes helps oncologists assess targeted treatment options. Depending on the selected test, DNA and RNA analysis may be combined to identify mutations and gene fusions.

The genes, types of genetic change and required sample are confirmed before testing.

Results & care

Your results, considered alongside your clinical picture.

The laboratory report includes the results, the genes and genetic changes examined, their interpretation and the method’s limitations. Findings are assessed alongside the pathology report, diagnosis and previous treatment.

Find the appropriate test

Our testing portfolio

Choose the right test
with your treating doctor.

Information for clinicians
NGS

Next-generation sequencing

Scientists operating sequencing instruments

DNA and RNA analysis

Next-generation sequencing examines multiple genes relevant to treatment selection. Depending on the panel, DNA analysis looks for mutations and RNA analysis looks for gene fusions.

Patients and families

Your guide to
molecular testing.

Two scientists reviewing laboratory information together
Information for patients

Agree the test details

Together, we confirm the analysis requested by your doctor, its cost, the expected reporting time, and the requirements for preparing and submitting the sample.

Prepare and submit the sample

Stored tissue from a biopsy or operation may be suitable for tumour testing. Suitability is assessed against the selected test’s requirements. Inherited BRCA1/2 testing requires a separate blood sample.

Discuss the results

The report is provided to your treating doctor, who will use the findings to help plan treatment and follow-up care.

Contact Epicheck

Discuss testing
with our team.

Cost and reporting time

We confirm the cost and expected reporting time before testing begins.